市場調查報告書

全球再生醫療市場規模調查:各技術,各用途,及各地區預測

Global Regenerative Medicine Market Size study, by Technology, by Application and Regional Forecasts 2019-2026

出版商 Bizwit Research & Consulting LLP 商品編碼 876664
出版日期 內容資訊 英文
商品交期: 2-3個工作天內
價格
Back to Top
全球再生醫療市場規模調查:各技術,各用途,及各地區預測 Global Regenerative Medicine Market Size study, by Technology, by Application and Regional Forecasts 2019-2026
出版日期: 2019年06月25日內容資訊: 英文
簡介

這份報告提供全球再生醫療市場的相關調查,彙整市場機會,各技術·用途·各地區的市場分析,競爭情形,主要企業的簡介等資訊。

第1章 摘要整理

  • 市場概述
  • 主要趨勢
  • 整體及各分類市場預測
    • 各技術
    • 各用途
    • 各地區
  • 調查方法
  • 調查的前提條件

第2章 再生醫療市場定義和範圍

  • 研究的目的
  • 市場定義和範圍
    • 產業的演進
    • 調查範圍
  • 研究涵蓋年份
  • 匯率

第3章 再生醫療市場動態

  • Seesaw分析
    • 市場成長要素
    • 市場課題
    • 市場機會

第4章 再生醫療市場產業分析

  • 波特的五力分析
    • 買主談判力
    • 供應商談判力
    • 新加入廠商的威脅
    • 替代品的威脅
    • 產業內的競爭
    • 波特五力分析的未來性方法
  • PEST分析
    • 政治
    • 經濟
    • 社會
    • 技術
  • 主要的購買標準(隨選)
  • 法律規範(隨選)
  • 投資/引進方案(隨選)
  • 分析師的建議與結論

第5章 再生醫療市場:各技術

  • 市場概述
  • 市場實際成果 - 潛在力模式
  • 主要市場參與企業
  • 再生醫療市場,子區隔分析
    • 幹細胞療法
    • 生醫材料
    • 生物組織工程
    • 其他

第6章 再生醫療市場:各用途

  • 市場概述
  • 市場實際成果 - 潛在力模式
  • 主要市場參與企業
  • 再生醫療市場,子區隔分析
    • 骨移植替代品
    • 骨關節疾病
    • 皮膚科
    • 心血管
    • 中樞神經系統
    • 其他

第7章 再生醫療市場:各地區

  • 再生醫療市場,地區市場概述
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 其他的歐洲
  • 亞洲
    • 中國
    • 印度
    • 日本
    • 其他的亞太地區
  • 南美
    • 巴西
    • 墨西哥
  • 世界其他地區的地區
    • 南美
    • 中東及非洲

第8章 競爭情形

  • 企業的市場佔有率(視資料情況而定)
  • 首位市場策略
  • 企業簡介
    • Acelity L.P. Inc.
    • Nuvasive Inc.
    • Vericel Corporation
    • Osiris Therapeutics Inc.
    • Stryker Corporation
    • Medtronic PLC

第9章 調查方法

  • 調查方法
    • 資料探勘
    • 分析
    • 市場預測
    • 檢驗
    • 出版
    • 調查的前提條件
目錄

Global Regenerative Medicine Market valued approximately USD 49.68 billion in 2018 is anticipated to grow with a healthy growth rate of more than 24.2% over the forecast period 2019-2026. The Regenerative Medicine Market is continuously growing in the global scenario at significant pace. Regenerative medicines are used to repair, replace, and regenerate tissues and organs affected by injury, disease, or natural aging process. These medicines restore the functionality of cells & tissues and are used in several degenerative disorders such as dermatology, neurodegenerative diseases, cardiovascular, and orthopedic applications. Stem cells are capable of proliferation and differentiation, which increase their importance in this field. Government & private funding to support the development of regenerative medicine, surging prevalence of chronic diseases & genetic disorders, escalating healthcare expenditure and rising geriatric population are the substantial driving factors of the market during the forecast period. Moreover, surging demand for organ transplantation and rising advancements in regenerative medicine is the factors that likely to create numerous opportunity in the near future. However, lack of clear regulatory guidelines and high cost of the treatment through the use of regenerative medicine are the factors that limiting the growth of the market during the forecast period.

The regional analysis of Global Regenerative Medicine Market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share with nearly 31.3% due to rapid technological advancements and high investment & funding to support development of regenerative medicines in the region. Europe is also estimated to grow at stable growth rate in the global Regenerative Medicine market over the upcoming years. Further, Asia-Pacific is anticipated to exhibit higher growth rate / CAGR over the forecast period 2019-2026 due to rising development of healthcare infrastructure and presence of large number of patients in the region.

The major market player included in this report are:

Acelity L.P. Inc.

Nuvasive Inc.

Vericel Corporation

Osiris Therapeutics Inc.

Stryker Corporation

Medtronic PLC

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Technology:

Stem Cell Therapy

Biomaterial

Tissue Engineering

Others

By Application:

Bone Graft Substitutes

Osteoarticular Diseases

Dermatology

Cardiovascular

Central Nervous System

Others

By Regions:

North America

U.S.

Canada

Europe

UK

Germany

Asia Pacific

China

India

Japan

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2016, 2017

Base year - 2018

Forecast period - 2019 to 2026

Target Audience of the Global Regenerative Medicine Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Key Trends
  • 1.3. Global & Segmental Market Estimates & Forecasts, 2016-2026 (USD Billion)
    • 1.3.1. Regenerative Medicine Market, by Technology, 2016-2026 (USD Billion)
    • 1.3.2. Regenerative Medicine Market, by Application, 2016-2026 (USD Billion)
    • 1.3.3. Regenerative Medicine Market, by Region, 2016-2026 (USD Billion)
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Regenerative Medicine Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Industry Evolution
    • 2.2.2. Scope of the Study
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Regenerative Medicine Market Dynamics

  • 3.1. See Saw Analysis
    • 3.1.1. Market Drivers
    • 3.1.2. Market Challenges
    • 3.1.3. Market Opportunities

Chapter 4. Regenerative Medicine Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Buyers
    • 4.1.2. Bargaining Power of Suppliers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model
  • 4.2. PEST Analysis
    • 4.2.1. Political Scenario
    • 4.2.2. Economic Scenario
    • 4.2.3. Social Scenario
    • 4.2.4. Technological Scenario
  • 4.3. Key Buying Criteria (On Demand)
  • 4.4. Regulatory Framework (On Demand)
  • 4.5. Investment Vs Adoption Scenario (On Demand)
  • 4.6. Analyst Recommendation & Conclusion

Chapter 5. Regenerative Medicine Market, by Technology

  • 5.1. Market Snapshot
  • 5.2. Market Performance - Potential Model
  • 5.3. Key Market Players
  • 5.4. Regenerative Medicine Market, Sub Segment Analysis
    • 5.4.1. Stem Cell Therapy
      • 5.4.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
    • 5.4.2. Biomaterial
      • 5.4.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 5.4.2.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 5.4.3. Tissue Engineering
      • 5.4.3.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 5.4.3.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 5.4.4. Others
      • 5.4.4.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 5.4.4.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)

Chapter 6. Regenerative Medicine Market, by Application

  • 6.1. Market Snapshot
  • 6.2. Market Performance - Potential Model
  • 6.3. Key Market Players
  • 6.4. Regenerative Medicine Market, Sub Segment Analysis
    • 6.4.1. Bone Graft Substitutes
      • 6.4.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 6.4.1.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 6.4.2. Osteoarticular Diseases
      • 6.4.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 6.4.2.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 6.4.3. Dermatology
      • 6.4.3.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 6.4.3.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 6.4.4. Cardiovascular
      • 6.4.4.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 6.4.4.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 6.4.5. Central Nervous System
      • 6.4.5.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 6.4.5.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 6.4.6. Others
      • 6.4.6.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 6.4.6.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)

Chapter 7. Regenerative Medicine Market, by Regional Analysis

  • 7.1. Regenerative Medicine Market, Regional Market Snapshot (2016-2026)
  • 7.2. North America Regenerative Medicine Market Snapshot
    • 7.2.1. U.S.
      • 7.2.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 7.2.1.2. Technology breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 7.2.1.3. Applications breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 7.2.2. Canada
      • 7.2.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 7.2.2.2. Technology breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 7.2.2.3. Application breakdown estimates & forecasts, 2016-2026 (USD Billion)
  • 7.3. Europe Regenerative Medicine Market Snapshot
    • 7.3.1. U.K.
      • 7.3.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 7.3.1.2. Technology breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 7.3.1.3. Application breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 7.3.2. Germany
      • 7.3.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 7.3.2.2. Technology breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 7.3.2.3. Application breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 7.3.3. Rest of Europe
      • 7.3.3.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 7.3.3.2. Technology breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 7.3.3.3. Application breakdown estimates & forecasts, 2016-2026 (USD Billion)
  • 7.4. Asia Regenerative Medicine Market Snapshot
    • 7.4.1. China
      • 7.4.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 7.4.1.2. Technology breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 7.4.1.3. Application breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 7.4.2. India
      • 7.4.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 7.4.2.2. Technology breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 7.4.2.3. Application breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 7.4.3. Japan
      • 7.4.3.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 7.4.3.2. Technology breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 7.4.3.3. Application breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 7.4.4. Rest of Asia Pacific
      • 7.4.4.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 7.4.4.2. Technology breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 7.4.4.3. Application breakdown estimates & forecasts, 2016-2026 (USD Billion)
  • 7.5. Latin America Regenerative Medicine Market Snapshot
    • 7.5.1. Brazil
      • 7.5.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 7.5.1.2. Technology breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 7.5.1.3. Application breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 7.5.2. Mexico
      • 7.5.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 7.5.2.2. Technology breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 7.5.2.3. Application breakdown estimates & forecasts, 2016-2026 (USD Billion)
  • 7.6. Rest of The World
    • 7.6.1. South America
      • 7.6.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 7.6.1.2. Technology breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 7.6.1.3. Application breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 7.6.2. Middle East and Africa
      • 7.6.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 7.6.2.2. Technology breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 7.6.2.3. Application breakdown estimates & forecasts, 2016-2026 (USD Billion)

Chapter 8. Competitive Intelligence

  • 8.1. Company Market Share (Subject to Data Availability)
  • 8.2. Top Market Strategies
  • 8.3. Company Profiles
    • 8.3.1. Acelity L.P. Inc.
      • 8.3.1.1. Overview
      • 8.3.1.2. Financial (Subject to Data Availability)
      • 8.3.1.3. Summary
      • 8.3.1.4. Recent Developments
    • 8.3.2. Nuvasive Inc.
    • 8.3.3. Vericel Corporation
    • 8.3.4. Osiris Therapeutics Inc.
    • 8.3.5. Stryker Corporation
    • 8.3.6. Medtronic PLC

Chapter 9. Research Process

  • 9.1. Research Process
    • 9.1.1. Data Mining
    • 9.1.2. Analysis
    • 9.1.3. Market Estimation
    • 9.1.4. Validation
    • 9.1.5. Publishing
    • 9.1.6. Research Assumption

List of Tables

List of Tables

  • TABLE 1. LIST OF SECONDARY SOURCES, USED IN THE STUDY OF REGENERATIVE MEDICINE MARKET
  • TABLE 2. LIST OF PRIMARY SOURCES, USED IN THE STUDY OF REGENERATIVE MEDICINE MARKET
  • TABLE 3. REGENERATIVE MEDICINE MARKET, REPORT SCOPE
  • TABLE 4. YEARS CONSIDERED FOR THE STUDY
  • TABLE 5. EXCHANGE RATES CONSIDERED
  • TABLE 6. REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY REGION 2016-2026 (USD BILLION)
  • TABLE 7. REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY TECHNOLOGY 2016-2026 (USD BILLION)
  • TABLE 8. REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY APPLICATION 2016-2026 (USD BILLION)
  • TABLE 9. REGENERATIVE MEDICINE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 10. REGENERATIVE MEDICINE MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 11. REGENERATIVE MEDICINE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 12. REGENERATIVE MEDICINE MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 13. REGENERATIVE MEDICINE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 14. REGENERATIVE MEDICINE MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 15. REGENERATIVE MEDICINE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 16. REGENERATIVE MEDICINE MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 17. REGENERATIVE MEDICINE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 18. REGENERATIVE MEDICINE MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 19. REGENERATIVE MEDICINE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 20. REGENERATIVE MEDICINE MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 21. REGENERATIVE MEDICINE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 22. REGENERATIVE MEDICINE MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 23. REGENERATIVE MEDICINE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 24. REGENERATIVE MEDICINE MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 25. REGENERATIVE MEDICINE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 26. REGENERATIVE MEDICINE MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 27. REGENERATIVE MEDICINE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 28. REGENERATIVE MEDICINE MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 29. REGENERATIVE MEDICINE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 30. REGENERATIVE MEDICINE MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 31. REGENERATIVE MEDICINE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 32. REGENERATIVE MEDICINE MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 33. REGENERATIVE MEDICINE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 34. REGENERATIVE MEDICINE MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 35. REGENERATIVE MEDICINE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 36. REGENERATIVE MEDICINE MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 37. REGENERATIVE MEDICINE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 38. REGENERATIVE MEDICINE MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 39. REGENERATIVE MEDICINE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 40. REGENERATIVE MEDICINE MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 41. REGENERATIVE MEDICINE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 42. REGENERATIVE MEDICINE MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 43. REGENERATIVE MEDICINE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 44. REGENERATIVE MEDICINE MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 45. U.S. REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 46. U.S. REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 47. U.S. REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 48. U.S. REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 49. U.S. REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 50. CANADA REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 51. CANADA REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 52. CANADA REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 53. CANADA REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 54. CANADA REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 55. UK REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 56. UK REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 57. UK REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 58. UK REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 59. UK REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 60. GERMANY REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 61. GERMANY REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 62. GERMANY REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 63. GERMANY REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 64. GERMANY REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 65. ROE REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 66. ROE REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 67. ROE REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 68. ROE REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 69. ROE REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 70. CHINA REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 71. CHINA REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 72. CHINA REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 73. CHINA REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 74. CHINA REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 75. INDIA REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 76. INDIA REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 77. INDIA REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 78. INDIA REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 79. INDIA REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 80. JAPAN REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 81. JAPAN REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 82. JAPAN REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 83. JAPAN REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 84. JAPAN REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 85. ROAPAC REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 86. ROAPAC REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 87. ROAPAC REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 88. ROAPAC REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 89. ROAPAC REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 90. BRAZIL REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 91. BRAZIL REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 92. BRAZIL REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 93. BRAZIL REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 94. BRAZIL REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 95. MEXICO REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 96. MEXICO REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 97. MEXICO REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 98. MEXICO REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 99. MEXICO REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 100. ROLA REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 101. ROLA REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 102. ROLA REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 103. ROLA REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 104. ROLA REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 105. ROW REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 106. ROW REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 107. ROW REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 108. ROW REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 109. ROW REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

List of Figures

List of Figures

  • FIG 1. REGENERATIVE MEDICINE MARKET, RESEARCH METHODOLOGY
  • FIG 2. REGENERATIVE MEDICINE MARKET, MARKET ESTIMATION TECHNIQUES
  • FIG 3. GLOBAL MARKET SIZE ESTIMATES & FORECAST METHODS
  • FIG 4. REGENERATIVE MEDICINE MARKET, KEY TRENDS 2017
  • FIG 5. REGENERATIVE MEDICINE MARKET, GROWTH PROSPECTS 2018-2026
  • FIG 6. REGENERATIVE MEDICINE MARKET, PORTERS 5 FORCE MODEL
  • FIG 7. REGENERATIVE MEDICINE MARKET, PEST ANALYSIS
  • FIG 8. REGENERATIVE MEDICINE MARKET, VALUE CHAIN ANALYSIS
  • FIG 9. REGENERATIVE MEDICINE MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 10. REGENERATIVE MEDICINE MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 11. REGENERATIVE MEDICINE MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 12. REGENERATIVE MEDICINE MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 13. REGENERATIVE MEDICINE MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 14. REGENERATIVE MEDICINE MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 15. REGENERATIVE MEDICINE MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 16. REGENERATIVE MEDICINE MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 17. REGENERATIVE MEDICINE MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 18. REGENERATIVE MEDICINE MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 19. REGENERATIVE MEDICINE MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 20. REGENERATIVE MEDICINE MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 21. REGENERATIVE MEDICINE MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 22. REGENERATIVE MEDICINE MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 23. REGENERATIVE MEDICINE MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 24. REGENERATIVE MEDICINE MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 25. REGENERATIVE MEDICINE MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 26. REGENERATIVE MEDICINE MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 27. REGENERATIVE MEDICINE MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 28. REGENERATIVE MEDICINE MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 29. REGENERATIVE MEDICINE MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 30. REGENERATIVE MEDICINE MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 31. REGENERATIVE MEDICINE MARKET, REGIONAL SNAPSHOT 2016 & 2026
  • FIG 32. NORTH AMERICA REGENERATIVE MEDICINE MARKET 2016 & 2026 (USD BILLON)
  • FIG 33. EUROPE REGENERATIVE MEDICINE MARKET 2016 & 2026 (USD BILLON)
  • FIG 34. ASIA PACIFIC REGENERATIVE MEDICINE MARKET 2016 & 2026 (USD BILLON)
  • FIG 35. LATIN AMERICA REGENERATIVE MEDICINE MARKET 2016 & 2026 (USD BILLON)
  • FIG 36. REGENERATIVE MEDICINE MARKET, COMPANY MARKET SHARE ANALYSIS (2017)
Back to Top